new_0222_0484|FHTX|Short Name|0|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return
new_0222_0484|FHTX|Long Name|1|1|Foghorn Therapeutics Inc Total Current Assets (Quarterly) (USD)|Foghorn Therapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|Foghorn Therapeutics Inc Inventories (Quarterly) (USD)|Foghorn Therapeutics Inc Net PP&E (Quarterly) (USD)|Foghorn Therapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|Foghorn Therapeutics Inc Total Liabilities (Quarterly) (USD)|Foghorn Therapeutics Inc Total Current Liabilities (Quarterly) (USD)|Foghorn Therapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|Foghorn Therapeutics Inc Total Deposits (Quarterly) (USD)|Foghorn Therapeutics Inc Book Value (Quarterly) (USD)|Foghorn Therapeutics Inc Retained Earnings (Quarterly) (USD)|Foghorn Therapeutics Inc Treasury Stock (Quarterly) (USD)|Foghorn Therapeutics Inc EV to Revenues|Foghorn Therapeutics Inc EV to Earnings|Foghorn Therapeutics Inc EV to Free Cash Flow|Foghorn Therapeutics Inc EV to Assets (Quarterly)|Foghorn Therapeutics Inc PS Ratio|Foghorn Therapeutics Inc PE Ratio|Foghorn Therapeutics Inc Price to Book Value|Foghorn Therapeutics Inc PEG Ratio|Foghorn Therapeutics Inc Debt to Equity Ratio|Foghorn Therapeutics Inc Dividend Yield|Foghorn Therapeutics Inc Shareholder Yield (TTM)|Foghorn Therapeutics Inc Percent of Shares Outstanding Short|Foghorn Therapeutics Inc Total Receivables (Quarterly) (USD)|Foghorn Therapeutics Inc Total Payables (Quarterly) (USD)|Foghorn Therapeutics Inc Total Capital Stock (Quarterly) (USD)|Foghorn Therapeutics Inc Return on Invested Capital|Foghorn Therapeutics Inc Quality Ratio Score|Foghorn Therapeutics Inc Momentum Score|Foghorn Therapeutics Inc Beta (1Y)|Foghorn Therapeutics Inc Sustainable Growth Rate (TTM)|Foghorn Therapeutics Inc Institutional Investor Ownership Percentage|Foghorn Therapeutics Inc Average Diluted Shares Outstanding (Quarterly)|Foghorn Therapeutics Inc Total Employees (Annual)|Foghorn Therapeutics Inc EPS Diluted (Quarterly) (USD)|Foghorn Therapeutics Inc Shares Outstanding|Foghorn Therapeutics Inc Repurchase of Capital Stock (Quarterly) (USD)|Foghorn Therapeutics Inc Ordinary Shares Number (Quarterly)|Foghorn Therapeutics Inc Payout Ratio|Foghorn Therapeutics Inc Quick Ratio (Quarterly)|Foghorn Therapeutics Inc Normalized Diluted EPS (Quarterly) (USD)|Foghorn Therapeutics Inc Stock Buybacks (Quarterly) (USD)|Foghorn Therapeutics Inc Effective Tax Rate (TTM)|Foghorn Therapeutics Inc Return on Equity|Foghorn Therapeutics Inc Net Income (TTM) (USD)|Foghorn Therapeutics Inc Revenue (TTM) (USD)|Foghorn Therapeutics Inc Dividend Per Share (Quarterly) (USD)|Foghorn Therapeutics Inc Revenue (Quarterly) (USD)|Foghorn Therapeutics Inc Gross Profit (Quarterly) (USD)|Foghorn Therapeutics Inc SG&A Expense (Quarterly) (USD)|Foghorn Therapeutics Inc Pre-Tax Income (Quarterly) (USD)|Foghorn Therapeutics Inc Net Income (Quarterly) (USD)|Foghorn Therapeutics Inc Net Interest Income (Quarterly) (USD)|Foghorn Therapeutics Inc Price (USD)|Foghorn Therapeutics Inc Total Return Price (USD)|Foghorn Therapeutics Inc Enterprise Value (USD)|Foghorn Therapeutics Inc 30-Day Average Daily Volume|Foghorn Therapeutics Inc 1 Year Price Returns (Daily)
new_0222_0484|FHTX|Unit|2|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric
new_0222_0484|FHTX||4|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily
new_0222_0484|FHTX||5|5|106.5|106.5|0|106.5|0|106.5|106.5|106.5|0|106.5|106.5|0|1.44099378882|92|1.44912280702|91|1.43827160494|0|1.44755244755|0|91.25|1.45180722892|0|15.2666666667|0|106.5|106.5|92|0|31|30.6666666667|92|30.5|91.375|122|91.375|31.25|0|106.5|92|91.25|91.375|0|0|92|91.4|92|0|91.25|0|91.375|91.375|91.375|91.375|1.45045045045|1.45045045045|1.45180722892|1.45214521452|1.4375
new_0222_0484|FHTX||6|6|6|6|0|6|0|6|6|6|0|6|6|0|161|1|285|3|162|0|286|0|4|332|0|30|0|6|6|1|0|2|3|1|14|8|1|8|12|0|6|1|4|8|0|0|1|5|1|0|4|0|8|8|8|8|333|333|332|303|80
new_0222_0484|FHTX||7|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily
new_0222_0484|FHTX|201909|201909|201909||||||||||||||||||||||||||||||||||22.1274||-0.5917||||||-0.5917|||||||||1.808|-13.092|-13.092|0.008|||||
new_0222_0484|FHTX|201912|201912|201912|16.885|14.981||3.713||110.358|12.652|97.706||-88.016|-94.136|||||||||||||||3.439|0|||||||22.1274||-0.6911|||35.6948|||-0.6911|||||||||1.666|-15.292|-15.292|-0.107|||||
new_0222_0484|FHTX|202003|202003|202003||||||||||||||||||||||||||||||||||22.1274||-0.6305||||||-0.6306|||||||||2.221|-13.952|-13.952|-0.229|||||
new_0222_0484|FHTX|202006|202006|202006|38.967|36.563||53.537||76.201|15.865|60.336||18.113|-123.811|||||||||||||||2.981|0.002|||||||22.1274||-0.7106|||35.6948|||-0.7106||||-58.059|||||1.911|-15.723|-15.723|-0.184|||||
new_0222_0484|FHTX|202008|202006|202006|||||||||||||||||||||||||||||||||||85||||||||||||||||||||||||
new_0222_0484|FHTX|202009|202009|202009|77.764|74.62||60.75||275.751|21.301|254.45||-133.323|-142.178||||||||||-0.1109|||||3.554|0.001|||||||35.6948||-0.5146|||35.6948||3.5031|-0.5126||||-63.334|||0.179||2.555|-18.367|-18.367|0.192|||||
new_0222_0484|FHTX|202010|202009|202009||||||||||||||||||||||0||0.0515|||||||||||||35.8136||||||||||||||||||15.98|15.98|510.5739||
new_0222_0484|FHTX|202011|202009|202009||||||||||||||||||||||0||0.0818|||||||||4.3473||||36.7654||||||||||||||||||20.2|20.2|682.8321||
new_0222_0484|FHTX|202012|202012|202012|190.687|185.77||62.332||109.407|18.846|90.561||146.187|-162.936||||-12.2108|2.2678|||5.1014||0.1344|0||0.9083||3.68|0.004||||||76.9292|36.7909|95|-0.5642|36.7909||36.7909||9.8573|-0.5582||||-68.8|||0.251||4.559|-20.758|-20.758|0.243|20.27|20.27|579.6355|167452.9667|
new_0222_0484|FHTX|202101|202012|202012|||||||||||||||-9.2889||||4.1526|||0||1.1212|||||||||76.9205||||36.8167||||||||||||||||||16.5|16.5|440.9338|168081.9|
new_0222_0484|FHTX|202102|202012|202012|||||||||||||||-9.2668||||4.1454|||0||1.5385|||||||||77.4354||||||||||||||||||||||16.46|16.46|439.8869|105673.5667|
new_0222_0484|FHTX|202103|202103|202103|165.315|160.917||61.235||104.722|16.332|88.39||125.164|-185.922||||-5.6773|1.4973|||3.8779||0.1577|0||2.0143||2.911|0.004||||||76.9532|36.8173||-0.62|36.8268||36.8268||9.8529|-0.62||||-77.834|||0.286||4.69|-22.986|-22.986|0.144|13.18|13.18|344.1992|103359.7|
new_0222_0484|FHTX|202104|202103|202103|||||||||||||||-4.3445||||3.2323|||0||1.9752|||||||||79.6079||||36.8461||||||||||||||||||10.98|10.98|263.3922|114249.6|
new_0222_0484|FHTX|202105|202103|202103|||||||||||||||-3.9981||||3.0645|||0||2.0022|||||||||79.4767||||36.8461||||||||||||||||||10.41|10.41|242.3899|76394.9667|
new_0222_0484|FHTX|202106|202106|202106|144.672|141.273||59.676||104.336|16.414|87.922||104.19|-209.033||273.2303|-3.1901|-4.1521|1.3037|391.8154||3.7749||0.1903|0||2.6141||3.406|0.004|-107.7982||||-163.6801|89.4452|36.8474||-0.63|36.8614||36.8614|0|8.6069|-0.63|||-163.6801|-85.222|0.995||0.279||4.898|-23.111|-23.111|0.15|10.67|10.67|271.8641|170381.3667|
new_0222_0484|FHTX|202107|202106|202106|||||||||||||214.6439||-3.2618||333.0615||3.2154|||0||2.5478|||||||||89.9423||||36.9369||||||||||||||||||9.07|9.07|213.5707|160138.5333|
new_0222_0484|FHTX|202108|202106|202106|||||||||||||359.7929||-5.4676||476.6414||4.6016|||0||2.4713|||||||||89.9454||||||||||||||||||||||12.98|12.98|357.994|68326.3|
new_0222_0484|FHTX|202109|202109|202109|123.953|120.842||57.952||105.087|19.296|85.791||80.982|-235.113||484.3711|-4.4666|-4.9708|2.2309|599.0852||6.3722||0.2459|0||2.3298||3.821|0.004|-111.3997||||-143.7732|85.3872|36.9718||-0.71|37.0448||37.0448|0|6.2625|-0.71|||-143.7732|-92.935|0.857||0.041||5.808|-26.08|-26.08|0.181|13.93|13.93|415.1061|90355.0667|
new_0222_0484|FHTX|202110|202109|202109|||||||||||||431.4637||-4.4278||545.7567||5.8123|||0||2.0515|||||||0.8837||85.4611||||37.0916||||||||||||||||||12.69|12.69|369.7644|55435.3667|-20.6875
new_0222_0484|FHTX|202111|202109|202109|||||||||||||382.9893||-3.9304||497.5891||5.2993|||0||1.8834||||||2|-0.5913||85.4599||||||||||||||||||||||11.57|11.57|328.2218|55652.0333|-42.7228
new_0222_0484|FHTX|202112|202112|202112|||||||||||||872.0617||-8.9494||983.5663||10.475|||0||2.5333||||||2|1.454||77.9686||||||||||||||||||||||22.87|22.87|747.3569|1063037.0333|12.8268
new_0222_0484|FHTX|202201|202112|202112|||||||||||||547.8889||-5.6226||661.4451||7.0444|||0||1.9516||||||6|2.3276||74.9775||||||||||||||||||||||15.38|15.38|469.5408|241326.3|-6.7879
new_0222_0484|FHTX|202202|202112|202112|||||||||||||359.6177||-3.6905||448.1312||4.7726|||0|||||||||||||||||||||||||||||||||10.42|10.42|308.1923|125291.9667|-30.2781